A ClinicalTrials.gov record lists MARITIME-1-EXTENSION, a follow-on trial intended to assess the long-term efficacy, safety and tolerability of maridebart cafraglutide in people with obesity or overweight.
A report said 150 research primates developed diarrhea during a study, but the available information does not identify the facility, species, cause, protocol or resulting findings.
Read More
A study listing describes an evaluation of INCB177054 alone and alongside retifanlimab in participants with selected advanced or metastatic solid tumors, but the supplied record provides few design details.
Read More
Qatar Fund for Development and the World Health Organization have signed an agreement for a US$4 million contribution intended to support WHO’s extended Thirteenth General Programme of Work.
Read More
CDC material listings identify a July 10, 2026 statement and several June updates concerning Ebola outbreaks in the Democratic Republic of Congo and Uganda, but the available records provide no underlying outbreak details.
Read More